[Elderly benefit from lower LDL-cholesterol]

Area of Science:

• Cardiology
• Geriatrics
• Preventive Medicine

Background:

• Low-density lipoprotein (LDL) cholesterol is a significant risk factor for myocardial infarction (heart attack) across all age groups.
• While the incidence of myocardial infarction increases with age, the relative risk associated with elevated LDL-cholesterol remains consistent.
• The elderly population experiences a higher absolute number of cardiovascular events linked to increased LDL levels.

Purpose of the Study:

• To evaluate the efficacy of LDL-cholesterol reduction in elderly individuals.
• To synthesize evidence from recent meta-analyses on lipid-lowering therapies in older adults.
• To determine if LDL-cholesterol reduction benefits are comparable between younger and older patient groups.

Main Methods:

• A meta-analysis was conducted, incorporating data from studies utilizing statins, ezetimibe, and PCSK9 inhibitors.
• The analysis focused on the relative risk reduction of cardiovascular events associated with LDL-cholesterol lowering.
• Patient age was a key factor in subgroup analysis, comparing individuals above and below 75 years of age.

Main Results:

• A reduction of 1 mmol/L in LDL-cholesterol was associated with a 26% relative risk reduction in cardiovascular events.
• This risk reduction was consistent across different age groups, including those above 75 years.
• The effectiveness of LDL-lowering therapies did not significantly differ based on age.

Conclusions:

• LDL-cholesterol reduction is an effective strategy for mitigating cardiovascular risk in the elderly.
• Therapeutic considerations for LDL-cholesterol lowering should extend to older individuals, irrespective of comorbidity status.
• These findings underscore the importance of aggressive lipid management in preventing myocardial infarction in aging populations.